Recurrence Interval Within 1 Year Leads to Death in Patients with Grade 2 Meningioma.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
10 2020
Historique:
received: 23 03 2020
revised: 14 05 2020
accepted: 15 05 2020
pubmed: 27 5 2020
medline: 31 3 2021
entrez: 27 5 2020
Statut: ppublish

Résumé

Grade 2 meningioma is more likely to recur than grade 1 meningioma. Recurrence decreases overall survival in patients with grade 2 meningioma. However, the clinical course of grade 2 meningioma with several repeated recurrences is poorly understood. The purpose of this study was to clarify the clinical characteristics of grade 2 meningioma with repeated recurrences. This study included 28 patients with grade 2 meningioma treated at our institution from January 1994 to December 2017. The relationship between survival and factors including age, sex, number of recurrences, malignant transformation, radiation therapy, tumor location, MIB-1 labeling index, Simpson grade, Karnofsky Performance Status, and surgical interval were analyzed. The average age at the initial operation was 53.4 years. The number of recurrences was 3.7 times on average during the follow-up of 113.9 months after the initial operation. An increasing number of recurrences resulted in shortening of the surgical interval, increase in the MIB-1 labeling index, and decrease in Karnofsky Performance Status. In fatal cases, the average surgical interval before death was approximately 1 year. Three factors were related to poor prognosis: number of recurrences (odds ratio, 1.620; P = 0.030), malignant transformation (odds ratio, 10.625; P = 0.019), and high MIB-1 labeling index (odds ratio, 1.089; P = 0.044). Shortening of the surgical interval within 1 year because of multiple recurrences led to death in patients with grade 2 meningioma. Malignant transformation was the most potent among the poor prognostic factors.

Identifiants

pubmed: 32454195
pii: S1878-8750(20)31116-5
doi: 10.1016/j.wneu.2020.05.145
pii:
doi:

Substances chimiques

Ki-67 Antigen 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e58-e65

Informations de copyright

Copyright © 2020. Published by Elsevier Inc.

Auteurs

Ryo Ukai (R)

Department of Neurosurgery, Sapporo Medical University, Sapporo, Hokkaido, Japan.

Masahiko Wanibuchi (M)

Department of Neurosurgery, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.

Katsuya Komatsu (K)

Department of Neurosurgery, Sapporo Medical University, Sapporo, Hokkaido, Japan.

Yusuke Kimura (Y)

Department of Neurosurgery, Sapporo Medical University, Sapporo, Hokkaido, Japan.

Yukinori Akiyama (Y)

Department of Neurosurgery, Sapporo Medical University, Sapporo, Hokkaido, Japan. Electronic address: akiyuki@sapmed.ac.jp.

Takeshi Mikami (T)

Department of Neurosurgery, Sapporo Medical University, Sapporo, Hokkaido, Japan.

Nobuhiro Mikuni (N)

Department of Neurosurgery, Sapporo Medical University, Sapporo, Hokkaido, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH